Paul Hopper (I actually wonder if he still holds any shares here from the ones issued and bought years ago. )
Has always stipulated that small biotechs don't have the distribution and sales team to go door knock and convince clinics to prescribe new drugs, nor do we have a large enough target market (in PTX-100) to warrent running any "Ask Your Doctor" ads in the US.
So as much as SYC likes to talk about Oz company bringing a drug to market themselves and implying PTX could be the first, there is good reason for it.
Even NEU partnered with NASDAQ listed Acadia Pharmaceuticals for their Rett syndrome treatment.
- Forums
- ASX - By Stock
- PTX
- Ann: Continued promising results in PTX-100 TCL trial
Ann: Continued promising results in PTX-100 TCL trial, page-59
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
0.002(5.13%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 4.0¢ | $3.956K | 97.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3550 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 66157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3550 | 0.040 |
7 | 489072 | 0.039 |
13 | 1669182 | 0.038 |
2 | 40513 | 0.037 |
6 | 498944 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 66157 | 1 |
0.042 | 180000 | 2 |
0.043 | 300000 | 2 |
0.044 | 100000 | 1 |
0.045 | 407000 | 3 |
Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |